The Department of Homeland Security’s Cybersecurity and Infrastructure Security Agency is proposing a sweeping cyber incident reporting structure across 16 critical sectors, according to its notice of proposed rulemaking, published in the Federal Register (PDF) on…
Continue Reading
By Hannah Nelson
December 13, 2023 – The Office of the National Coordinator for Health Information Technology (ONC) has finalized a rule to support health IT interoperability and artificial intelligence (AI) transparency.
The Health Data, Technology, and…
What You Should Know:
– The U.S. Department of Health and Human Services (HHS) took a major step forward in healthcare data sharing and artificial intelligence (AI) transparency with the finalization of the Health Data,…
Continue Reading
The following is a guest article by Nick Barger, PharmD, Vice President, Product at DrFirst. This article is the second in the Healthcare Regulatory Talk series.
More regulatory churn is coming to shake up e-prescribing,…
The Biden Administration has proposed significant updates to Section 504 of the Rehabilitation Act of 1973 rule. The rule, Nondiscrimination on the Basis of Disability in Programs or Activities Receiving Federal Financial Assistance, updates…
Continue Reading
When the Drug Enforcement Administration (DEA) released its proposed rule that would remove some of the Covid-19 telehealth flexibilities for the prescribing of controlled substances, it caused an uproar from telehealth companies and advocates….
Continue Reading
What You Should Know:
– The U.S. Department of Health and Human Services (HHS) released a proposed rule for public comment that would establish disincentives for healthcare providers found by the HHS Office of Inspector…
Continue Reading
By Hannah Nelson
October 30, 2023 – The Department of Health and Human Services (HHS) has released a proposed rule for public comment that would establish disincentives for healthcare providers found by the HHS Office of…
Continue Reading
The DEA has extended remote prescribing of controlled substances until the end of 2024, granting a second extension to consider new regulations. This move eliminates the proposed rule requiring in-person visits for controlled medication…
Continue Reading
As the Drug Enforcement Administration (DEA) holds listening sessions this week for its proposed rule that rolls back Covid-19 flexibilities for the virtual prescribing of controlled substances, four mental health companies issued a letter…
Continue Reading
